Get started
Author

Maria Giulia Zampino

Observed names: M G Zampino, M. G. Zampino, M. Giulia Zampino, M. Zampino, M.G. Zampino, MARIA ZAMPINO, MG Zampino, MG. Zampino, Maria G Zampino, Maria G. Zampino, Maria Zampino, Zampino, M. G., Zampino, Maria Giulia
Observed institutions: Universität Hamburg, Merck KGaA, Darmstadt (Germany), University of Milan, Mario Negri Institute for Pharmacological Research, Hôpital Beaujon, Institut Gustave Roussy, Ospedale degli Infermi, Wilhelminen Hospital, Universitätsklinikum Tübingen, Ospedale San Carlo, Hôpital Saint-Antoine, University Hospital of Geneva, Istituto Oncologico Veneto, Pitié-Salpêtrière Hospital, Hôpital Ambroise-Paré, IRCCS Ospedale San Raffaele, Fondazione IRCCS Istituto Nazionale dei Tumori, Azienda Ospedaliera Carlo Poma, Hôpital Tenon, Moscow City Oncology Hospital №62, European Institute of Oncology
ORCID: 0000-0001-5142-1778
Observed ORCID: 0000-0001-5142-1778
OpenAlex ID: A5083277135
Gemcitabine in Combination With Oxaliplatin Compared With Gemcitabine Alone in Locally Advanced or Metastatic Pancreatic Cancer: Results of a GERCOR and GISCAD Phase III Trial
2005 · C. Louvet, R. Labianca, et al. · Journal of Clinical Oncology · 954
PDF
The EGFR-specific antibody cetuximab combined with chemotherapy triggers immunogenic cell death
2016 · Chiara Pozzi, Alessandro Cuomo, et al. · Nature Medicine · 303
Tucatinib plus trastuzumab for chemotherapy-refractory, HER2-positive, RAS wild-type unresectable or metastatic colorectal cancer (MOUNTAINEER): a multicentre, open-label, phase 2 study
2023 · John H Strickler, Andrea Cercek, et al. · The Lancet Oncology · 277
CT Perfusion for the Monitoring of Neoadjuvant Chemotherapy and Radiation Therapy in Rectal Carcinoma: Initial Experience
2007 · Massimo Bellomi, Giuseppe Petralia, et al. · Radiology · 175
Cholangiocarcinoma
2008 · Stefania Mosconi, Giordano D. Beretta, et al. · Critical Reviews in Oncology/Hematology · 168
Multicenter randomized trial of dacarbazine alone or in combination with two different doses and schedules of interferon alfa-2a in the treatment of advanced melanoma.
1994 · E Bajetta, A Di Leo, et al. · Journal of Clinical Oncology · 150
Cetuximab plus 5-FU/FA/oxaliplatin (FOLFOX-4) versus FOLFOX-4 in the first-line treatment of metastatic colorectal cancer (mCRC): OPUS, a randomized phase II study
2007 · C. Bokemeyer, I. Bondarenko, et al. · Journal of Clinical Oncology · 101
Surgical outcome after docetaxel-based neoadjuvant chemotherapy in locally-advanced gastric cancer.
2010 · Roberto Biffi, Nicola Fazio, et al. · PubMed Central · 89
Lung Metastases From Colorectal Cancer: Analysis of Prognostic Factors in a Single Institution Study
2014 · Maria Giulia Zampino, Patrick Maisonneuve, et al. · The Annals of Thoracic Surgery · 85
FOLFOX or CAPOX in Stage II to III Colon Cancer: Efficacy Results of the Italian Three or Six Colon Adjuvant Trial
2018 · Alberto Sobrero, Sara Lonardi, et al. · Journal of Clinical Oncology · 68
Anti-EGFR Rechallenge in Patients With Refractory ctDNA RAS/BRAF wt Metastatic Colorectal Cancer
2024 · Davide Ciardiello, Erika Martinelli, et al. · JAMA Network Open · 64
PDF
Panitumumab Plus Trifluridine-Tipiracil as Anti–Epidermal Growth Factor Receptor Rechallenge Therapy for Refractory RAS Wild-Type Metastatic Colorectal Cancer
2023 · Stefania Napolitano, Vincenzo De Falco, et al. · JAMA Oncology · 64
PDF
LBA28 The PEGASUS trial: Post-surgical liquid biopsy-guided treatment of stage III and high-risk stage II colon cancer patients
2023 · S. Lonardi, F. Pietrantonio, et al. · Annals of Oncology · 59
PDF
Phase III trial comparing 3–6 months of adjuvant FOLFOX4/XELOX in stage II–III colon cancer: safety and compliance in the TOSCA trial
2016 · S. Lonardi, A. Sobrero, et al. · Annals of Oncology · 59
PDF
Randomized phase II trial of avelumab alone or in combination with cetuximab for patients with previously treated, locally advanced, or metastatic squamous cell anal carcinoma: the CARACAS study
2021 · Sara Lonardi, Alessandra Anna Prete, et al. · Journal for ImmunoTherapy of Cancer · 56
PDF
Independent prognostic value of fascin immunoreactivity in stage III–IV colonic adenocarcinoma
2007 · G Puppa, P Maisonneuve, et al. · British Journal of Cancer · 52
PDF
Assessment of Duration and Effects of 3 vs 6 Months of Adjuvant Chemotherapy in High-Risk Stage II Colorectal Cancer
2020 · Fausto Petrelli, Roberto Labianca, et al. · JAMA Oncology · 51
PDF
Preoperative versus postoperative docetaxel–cisplatin–fluorouracil (TCF) chemotherapy in locally advanced resectable gastric carcinoma: 10-year follow-up of the SAKK 43/99 phase III trial
2015 · N. Fazio, R. Biffi, et al. · Annals of Oncology · 47
PDF
“Waiting and the Waiting Room: How Do You Experience Them?” Emotional Implications and Suggestions from Patients with Cancer
2010 · Chiara Catania, Tommaso De Pas, et al. · Journal of Cancer Education · 46
Treatments for colorectal liver metastases: A new focus on a familiar concept
2016 · M.G. Zampino, E. Magni, et al. · Critical Reviews in Oncology/Hematology · 41
Colorectal cancer, Vitamin D and microbiota: A double-blind Phase II randomized trial (ColoViD) in colorectal cancer patients
2022 · Federica Bellerba, Davide Serrano, et al. · Neoplasia · 40
PDF
Individual data meta-analysis for the study of survival after pulmonary metastasectomy in colorectal cancer patients: A history of resected liver metastases worsens the prognosis
2018 · Jon Zabaleta, Tomohiko Iida, et al. · European Journal of Surgical Oncology · 40
PDF
Capecitabine Initially Concomitant to Radiotherapy Then Perioperatively Administered in Locally Advanced Rectal Cancer
2009 · Maria Giulia Zampino, Elena Magni, et al. · International Journal of Radiation Oncology*Biology*Physics · 39
Panitumumab plus trifluridine/tipiracil as anti‐ EGFR rechallenge therapy in patients with refractory RAS wild‐type metastatic colorectal cancer: Overall survival and subgroup analysis of the randomized phase II VELO trial
2023 · Stefania Napolitano, Davide Ciardiello, et al. · International Journal of Cancer · 38
PDF
Detection of circulating tumor cells in patients with locally advanced rectal cancer undergoing neoadjuvant therapy followed by curative surgery
2014 · Elena Magni, Edoardo Botteri, et al. · International Journal of Colorectal Disease · 38
Works count: 184
Citation count: 4,611
H-index: 34
I10-index: 87
Year
Topic
Type